Inventor · disambiguated record
Irene Noguera-Troise
Also filed as: NOGUERA-TROISE IRENE
7 granted patents·6 pending applications·159 citations·filing 2007–2020
88Inventor score
Top patents by PatentIndex Score
13 records- 0197US7534868B1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2009·Granted May 19, 2009·38 cites·6 claims
- 0297US7488806B2Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2008·Granted Feb 10, 2009·41 cites·8 claims
- 0395US7919593B2Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2007·Granted Apr 5, 2011·25 cites·22 claims
- 0494US8048418B2Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonistsREGENERON PHARMA·Filed 2009·Granted Nov 1, 2011·34 cites·6 claims
- 0586US8840886B2Method of treating cancer with DLL4 antagonist and chemotherapeutic agentREGENERON PHARMA·Filed 2013·Granted Sep 23, 2014·10 cites·5 claims
- 0682US8518887B2Method of treating cancer with DLL4 antagonist and chemotherapeutic agentNOGUERA-TROISE IRENE·Filed 2010·Granted Aug 27, 2013·11 cites·17 claims
- 0776US11820815B2Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2020·Granted Nov 21, 2023·0 cites·5 claims
- 0867US2015191534A1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2014·Application pending·0 cites
- 0966US2015232545A1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2014·Application pending·0 cites
- 1063US2017029492A1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2016·Application pending·0 cites
- 1159US2011150905A1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2011·Application pending·0 cites
- 1259US2015376267A1Human antibodies to human delta like ligand 4REGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1356US2015064189A1Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic AgentREGENERON PHARMA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Irene Noguera-Troise files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →